 IDEAYA Biosciences NASDAQ:IDYA was upgraded by analysts at JPMorgan Chase Co. from a neutral rating to an overweight rating in a note issued to investors on Monday, Briefing.com Automated Import reports. The brokerage currently has a 28.00 price objective on the stock. JPMorgan Chase Co.s price objective would indicate a potential upside of ... 